Hospira 8.4% Sodium Bicarbonate PF24 50 mL Vial
Hospira's preservative-free 8.4% sodium bicarbonate injection in 50 mL Pharmacy Bulk Vial (PF24) for multiple withdrawals within 24 hours, used in hospital settings for acid-base correction. Under HTS 3004.90.92.66 for its injection form, sodium bicarbonate content, and therapeutic electrolytic balance role.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If organo-sulfur therapeutic compound mixed
Medicaments containing specific organo-sulfur compounds classify in 3003.31, not general electrolyte preps.
If pre-filled syringe as medical instrument part
Syringes and needles as instruments classify in Chapter 90, but filled with medicaments go to Chapter 30.
If put up for retail sale as appliance
Wound dressings or appliances (not injections) go to 3005; form determines primary heading.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Certify PF24 stability; include bar-code labeling per Drug Supply Chain Security Act for import clearance
• Declare as 'multi-dose vial' accurately; bulk packs may trigger pharmacy compounding reviews
• Monitor for sodium content limits; excess impurities can lead to FDA detention without analysis
Related Products under HTS 3004.90.92.66
Sodium Bicarbonate Injection 8.4% 50 mEq/50 mL Syringe
This is a sterile 8.4% sodium bicarbonate injection in a prefilled 50 mL syringe, providing 50 mEq of sodium and bicarbonate for immediate use in metabolic acidosis treatment. It falls under HTS 3004.90.92.66 as a mixed product (sodium bicarbonate in water) put up in measured doses in injection form, primarily affecting electrolytic and water balance for therapeutic uses.
BD Sodium Bicarbonate 7.5% 44.6 mEq IV Vial
BD brand 7.5% sodium bicarbonate injection in a 50 mL single-dose vial, containing 44.6 mEq for IV administration in cardiac arrest and severe acidosis. Classified under HTS 3004.90.92.66 due to its injection form, measured dose, and primary role in correcting electrolytic imbalances.
Sodium Bicarbonate 4.2% 25 mEq Neonatal Injection
Dilute 4.2% sodium bicarbonate injection in 25 mL ampule for neonatal resuscitation and acidosis correction, delivering 25 mEq in low-volume form suitable for infants. It qualifies for HTS 3004.90.92.66 as an injection-form product in measured doses affecting caloric and electrolytic balance.
AMT Sodium Bicarbonate 7.5% 50 mEq/50 mL Carpuject
AMT brand 7.5% sodium bicarbonate in locked Carpuject syringe system (50 mEq/50 mL) for rapid EMS deployment in resuscitation protocols. HTS 3004.90.92.66 applies as it's an injectable measured-dose preparation primarily for electrolytic and water balance therapy.